Pharmaceutical R&D productivity has declined over the last decade despite increasing investments. Recent trends, however, indicate a potential reversal of this trend fueled by a wave of new biologics, vaccines and highly selective NCEs directed against targets validated by human genetics, focus on new disease areas including orphan and genetic diseases and more precise tailoring of medicines to their target populations.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3567426 | PMC |
| http://dx.doi.org/10.1186/2001-1326-1-7 | DOI Listing |
Publication Analysis
Top Keywords
precision medicine
4
medicine approach
4
approach r&d
4
r&d delivering
4
delivering superior
4
superior medicines
4
medicines patients
4
patients pharmaceutical
4
pharmaceutical r&d
4
r&d productivity
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!